Frans H.J. Claas

28.7k citations

585 papers · 19.2k indexed · 3 hit papers · h-index 64

Immunology top 0.1%
Transplantation top 0.01%
Surgery top 0.2%
Public Health, Environmental and Occupational Health top 0.2%
Epidemiology top 0.5%

Co-authors: Dave L. Roelen Sicco A. Scherjon Ilias I.N. Doxiadis Arend Mulder Jon J. van Rood Humphrey H.H. Kanhai Sebastiaan Heidt Willem E. Fibbe
Topics: Renal Transplantation Outcomes and Treatments (227 papers)T-cell and B-cell Immunology (174 papers)Immune Cell Function and Interaction (121 papers)
Cited by: Transplantation Immunology Obstetrics and Gynecology
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Frans H.J. Claas

581 papers receiving 18.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

2004 922 citations Sicco A. Scherjon, Frans H.J. Claas et al. profile →
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

2016 660 citations Arend Mulder, Frans H.J. Claas et al. profile →
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

2003 590 citations Sicco A. Scherjon, Frans H.J. Claas et al. Blood profile →

Peers

Countries citing papers authored by Frans H.J. Claas

Since Specialization

Citations

This map shows the geographic impact of Frans H.J. Claas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frans H.J. Claas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frans H.J. Claas more than expected).

Fields of papers citing papers by Frans H.J. Claas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frans H.J. Claas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frans H.J. Claas. The network helps show where Frans H.J. Claas may publish in the future.

Co-authorship network of co-authors of Frans H.J. Claas

This figure shows the co-authorship network connecting the top 25 collaborators of Frans H.J. Claas. A scholar is included among the top collaborators of Frans H.J. Claas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frans H.J. Claas. Frans H.J. Claas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Introduction of the donor centre virtual crossmatch in Eurotransplant 2024 ·HLA ·Sebastiaan Heidt,Cynthia S. M. Kramer,Geert W. Haasnoot,Alexander H. Schmidt,Yvonne M. Zoet,Frans H.J. Claas,Serge Vogelaar	4
2	A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendors 2023 ·HLA ·Gonca E. Karahan,Geert W. Haasnoot,(unknown),Frans H.J. Claas,Dave L. Roelen,Sebastiaan Heidt	5
3	Chimeric HLA antibody receptor T cells for targeted therapy of antibody‐mediated rejection in transplantation 2023 ·HLA ·(unknown),Jordi Rovira,(unknown),(unknown),(unknown),María José Ramírez-Bajo,Elisenda Bañón-Maneus,(unknown),(unknown),Frans H.J. Claas,Arend Mulder,Sebastiaan Heidt,Manel Juan,(unknown),Josep M. Campistol,Eduard Palou,Fritz Diekmann	3
4	Site‐directed mutagenesis of HLA molecules reveals the functional epitope of a human HLA‐A1/A36‐specific monoclonal antibody 2022 ·HLA ·Shi‐Yuan Meng,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ned Van Eps,Eric Ka‐Wai Hui,David Suh,Quansheng Zhu,Rui Pei,Cynthia S. M. Kramer,Frans H.J. Claas,David Lowe,Sebastiaan Heidt	4
5	Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study 2021 ·American Journal of Transplantation ·Marlies E. J. Reinders,(unknown),Sanne H. Hendriks,(unknown),(unknown),Aiko P. J. de Vries,Melissa van Pel,Helene Roelofs,Volkert A.L. Huurman,Pauline Meij,Dirk Jan A. R. Moes,Willem E. Fibbe,Frans H.J. Claas,Dave L. Roelen,Cees van Kooten,Jesper Kers,Sebastiaan Heidt,Ton J. Rabelink,Johan W. de Fijter	30
6	Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study 2020 ·American Journal of Transplantation ·(unknown),(unknown),Sebastiaan Heidt,Dave L. Roelen,Melissa van Pel,Helene Roelofs,Volkert A.L. Huurman,Ingeborg M. Bajema,Dirk Jan A. R. Moes,Willem E. Fibbe,Frans H.J. Claas,Cees van Kooten,Ton J. Rabelink,Johan W. de Fijter,Marlies E. J. Reinders	34
7	Low incidence of IgA isotype of HLA antibodies in alloantigen exposed individuals 2020 ·HLA ·(unknown),Gonca E. Karahan,(unknown),(unknown),Aiko P. J. de Vries,Cees van Kooten,Cynthia S. M. Kramer,Dave L. Roelen,Frans H.J. Claas,Sebastiaan Heidt	2
8	Maternal and child human leukocyte antigens in congenital cytomegalovirus infection 2018 ·Journal of Reproductive Immunology ·Roberta Rovito,Frans H.J. Claas,Geert W. Haasnoot,Dave L. Roelen,Aloys C.M. Kroes,Ann C.T.M. Vossen	2
9	Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies 2018 ·Transplant International ·Gonca E. Karahan,Frans H.J. Claas,Sebastiaan Heidt	7
10	Human and Rhesus Macaque KIR Haplotypes Defined by Their Transcriptomes 2018 ·The Journal of Immunology ·(unknown),(unknown),Wendy Swelsen,Ńel Otting,Annemiek J. M. de Vos‐Rouweler,Diënne G. Elferink,Gaby G. M. Doxiadis,Frans H.J. Claas,Neubury M. Lardy,Natasja G. de Groot,Ronald E. Bontrop	17
11	Infection with a virus generates a polyclonal immune response with broad alloreactive potential 2018 ·Human Immunology ·(unknown),(unknown),Paula P.M.C. van Miert,Xiaoqian Zhang,Jacqueline D.H. Anholts,Frans H.J. Claas	8
12	The long and winding road towards epitope matching in clinical transplantation 2018 ·Transplant International ·Cynthia S. M. Kramer,Moshe Israeli,Arend Mulder,Ilias I.N. Doxiadis,Geert W. Haasnoot,Sebastiaan Heidt,Frans H.J. Claas	34
13	Pretransplantation Donor–Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation 2016 ·American Journal of Transplantation ·Herman F. Wunderink,E. van der Meijden,Caroline S. de Brouwer,Marko J.K. Mallat,Geert W. Haasnoot,Erik W. van Zwet,Eric C. J. Claas,Johan W. de Fijter,Aloys C.M. Kroes,(unknown),Antoine Touzé,Frans H.J. Claas,Joris I. Rotmans,Mariet C.W. Feltkamp	65
14	The interplay between antiviral immunity and allo-immune reactivity after renal transplantation 2014 ·Transplant Immunology ·(unknown),Kirstin M. Heutinck,(unknown),Geurt Stokman,Sandrine Florquin,Cees van Kooten,Gina Stella García-Romo,Jurjen M. Ruben,M. van de Vrie,Luuk B. Hilbrands,(unknown),Irma Joosten,(unknown),Frans H.J. Claas	2
15	Diagnosis of Early Pancreas Graft Failure via Antibody-Mediated Rejection: Single-Center Experience With 256 Pancreas Transplantations 2014 ·American Journal of Transplantation ·Hanneke de Kort,Marko J.K. Mallat,Cees van Kooten,Emile de Heer,(unknown),A M van der Wal,Candice Roufosse,Dave L. Roelen,Jan A. Bruijn,Frans H.J. Claas,Johan W. de Fijter,Ingeborg M. Bajema	17
16	Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94 2013 ·Proceedings of the National Academy of Sciences ·Kuldeep Cheent,(unknown),Sorcha Cassidy,Mengya Liu,(unknown),Arend Mulder,Frans H.J. Claas,Marco A. Purbhoo,Salim I. Khakoo	26
17	Human monoclonal antibody reactivity with HLA class I epitopes defined by pairs of mismatched eplets and self eplets 2011 ·Data Archiving and Networked Services (DANS) ·René J. Duquesnoy,(unknown),Arend Mulder,(unknown),Frans H.J. Claas,(unknown)	2
18	Allo-HLA reactivity of virus-specific memory T cells is common 2010 ·Blood ·Avital L. Amir,Lloyd D’Orsogna,Dave L. Roelen,Marleen M. van Loenen,Renate S. Hagedoorn,Renate de Boer,Menno A. W. G. van der Hoorn,Michel G.D. Kester,Ilias I.N. Doxiadis,J.H. Frederik Falkenburg,Frans H.J. Claas,Mirjam H.M. Heemskerk	231
19	Peptide antagonism as a mechanism for NK cell activation 2010 ·Proceedings of the National Academy of Sciences ·Lena Fadda,Gwenoline Borhis,Parvin S. Ahmed,Kuldeep Cheent,Sophie V. Pageon,Angelica Cazaly,(unknown),Derek Middleton,Arend Mulder,Frans H.J. Claas,Tim Elliott,Daniel M. Davis,Marco A. Purbhoo,Salim I. Khakoo	133
20	Comparison of Macrophage Phenotype Between Decidua Basalis and Decidua Parietalis by Flow Cytometry 2008 ·Placenta ·Urška Repnik,Tamara Tilburgs,Dave L. Roelen,Barbara J. van der Mast,Humphrey H.H. Kanhai,Sicco A. Scherjon,Frans H.J. Claas	67

About Frans H.J. Claas

Frans H.J. Claas is a scholar working on Transplantation, Immunology and Hematology, having authored 585 papers that have together received 19.2k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (227 papers), T-cell and B-cell Immunology (174 papers) and Immune Cell Function and Interaction (121 papers). The work is most often cited by research in Transplantation (5.2k citations), Immunology (8.8k citations) and Obstetrics and Gynecology (2.0k citations). Frans H.J. Claas has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Dave L. Roelen, Sicco A. Scherjon, Ilias I.N. Doxiadis, Arend Mulder, Jon J. van Rood, Humphrey H.H. Kanhai, Sebastiaan Heidt, Willem E. Fibbe, Geert W. Haasnoot and Guido G. Persijn. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact